Hyperlipidemia in COPD is associated with decreased incidence of pneumonia and mortality: a nationwide health insurance data-based retrospective cohort study

References

• ChenJCManninoDMWorldwide epidemiology of chronic obstructive pulmonary diseaseCurr Opin Pulm Med19995939910813258
   PubMedGoogle Scholar
• MurrayCJLopezADAlternative projections of mortality and disability by cause 1990–2020: Global Burden of Disease StudyLancet1997349149815049167458
   PubMed Web of Science ®Google Scholar
• ShirtcliffePWeatherallMTraversJBeasleyRThe multiple dimensions of airways disease: targeting treatment to clinical phenotypesCurr Opin Pulm Med201117727821150622
   PubMed Web of Science ®Google Scholar
• Global Strategy for Diagnosis Management, and Prevention of COPD – 2016Global Initiative for Chronic Obstructive Lung Disease (GOLD)2016 Available from: http://www.goldcopd.com/Accessed Feb 17, 2016
   Google Scholar
• TantucciCCOPD and osteoporosis: something more than a comorbidityEndocrine2012425622581203
   PubMed Web of Science ®Google Scholar
• SethiSInfection as a comorbidity of COPDEur Respir J2010351209121520513910
   PubMed Web of Science ®Google Scholar
• IncalziRACorsonelloAPedoneCBattagliaSPaglinoGBelliaVExtrapulmonary Consequences of COPD in the Elderly Study Investigators. Chronic renal failure: a neglected comorbidity of COPDChest201013783183719903974
   PubMed Web of Science ®Google Scholar
• van den BemtLSchermerTBorHThe risk for depression comorbidity in patients with COPDChest200913510811418689578
   PubMed Web of Science ®Google Scholar
• CarratuPRestaOIs obstructive sleep apnoea a comorbidity of COPD and is it involved in chronic systemic inflammatory syndrome?Eur Respir J2008311381138218515563
   PubMed Web of Science ®Google Scholar
• ManninoDMAguayoSMPettyTLReddSCLow lung function and incident lung cancer in the United States: data from the First National Health and Nutrition Examination Survey follow-upArch Intern Med20031631475148012824098
   PubMed Web of Science ®Google Scholar
• van ManenJGBindelsPJDekkerFWThe influence of COPD on health-related quality of life independent of the influence of comorbidityJ Clin Epidemiol2003561177118414680668
   PubMed Web of Science ®Google Scholar
• TerzanoCContiVDi StefanoFComorbidity, hospitalization, and mortality in COPD: results from a longitudinal studyLung201018832132920066539
   PubMed Web of Science ®Google Scholar
• SinDDAnthonisenNRSorianoJBAgustiAGMortality in COPD: role of comorbiditiesEur Respir J2006281245125717138679
   PubMed Web of Science ®Google Scholar
• StolzDChrist-CrainMMorgenthalerNGCopeptin, C-reactive protein, and procalcitonin as prognostic biomarkers in acute exacerbation of COPDChest20071311058106717426210
   PubMed Web of Science ®Google Scholar
• GanWQManSFSenthilselvanASinDDAssociation between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysisThorax20045957458015223864
   PubMed Web of Science ®Google Scholar
• DaneshJWheelerJGHirschfieldGMC-reactive protein and other circulating markers of inflammation in the prediction of coronary heart diseaseN Engl J Med20043501387139715070788
   PubMed Web of Science ®Google Scholar
• SidneySSorelMQuesenberryCPJrDeLuiseCLanesSEisnerMDCOPD and incident cardiovascular disease hospitalizations and mortality: Kaiser Permanente Medical Care ProgramChest20051282068207516236856
   PubMed Web of Science ®Google Scholar
• CurkendallSMDeLuiseCJonesJKCardiovascular disease in patients with chronic obstructive pulmonary disease, Saskatchewan Canada cardiovascular disease in COPD patientsAnn Epidemiol200616637016039877
   PubMed Web of Science ®Google Scholar
• CurkendallSMLanesSde LuiseCChronic obstructive pulmonary disease severity and cardiovascular outcomesEur J Epidemiol20062180381317106760
   PubMed Web of Science ®Google Scholar
• GrundySMCleemanJIDanielsSRAmerican Heart Association; National Heart, Lung, and Blood InstituteDiagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific StatementCirculation20051122735275216157765
   PubMed Web of Science ®Google Scholar
• JooHParkJLeeSDOhYMComorbidities of chronic obstructive pulmonary disease in Koreans: a population-based studyJ Korean Med Sci20122790190622876057
   PubMed Web of Science ®Google Scholar
• DivoMCoteCde TorresJPComorbidities and Risk of Mortality in Patients with chronic obstructive pulmonary diseaseAm J Respir Crit Care Med201218615516122561964
   PubMed Web of Science ®Google Scholar
• CelliBRCoteCGMarinJMThe body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary diseaseN Engl J Med20043501005101214999112
   PubMed Web of Science ®Google Scholar
• CaoCWangRWangJBunjhooHXuYXiongWBody mass index and mortality in chronic obstructive pulmonary disease: a meta-analysisPLoS One20127e4389222937118
   PubMed Web of Science ®Google Scholar
• National Health Insurance Research Database Available from: http://nhird.nhir.org.tw/en/index/htmAccessed April 18, 2016
   Google Scholar
• KuoLCYangPCKuoSHTrends in the mortality of chronic obstructive pulmonary disease in Taiwan, 1981–2002J Formos Med Assoc2005104899315765162
   PubMed Web of Science ®Google Scholar
• JensenHHGodtfredsenNSLangePPotential misclassification of causes of death from COPDEur Respir J20062878178516807258
   PubMed Web of Science ®Google Scholar
• NegewoNAMcDonaldVMGibsonPGComorbidity in chronic obstructive pulmonary diseaseRespir Investig2015536249258
   PubMed Web of Science ®Google Scholar
• BarnesPJMechanisms of development of multimorbidity in the elderlyEur Respir J20154579080625614163
   PubMed Web of Science ®Google Scholar
• WoodruffPGAgustiARocheNSinghDMartinezFJCurrent concepts in targeting chronic obstructive pulmonary disease pharmacotherapy: making progress towards personalized managementLancet20153851789179825943943
   PubMed Web of Science ®Google Scholar
• SpruitMAPittaFMcAuleyEZuWallackRLNiciLPulmonary rehabilitation and physical activity in patients with chronic obstructive pulmonary diseaseAm J Respir Crit Care Med201519292493326161676
   PubMed Web of Science ®Google Scholar
• Farver-VestergaardIJacobsenDZachariaeREfficacy of psychosocial intervention on psychological and physical outcomes in chronic obstructive pulmonary disease: a systemic review and mega-analysisPsychother Psychosom201584375025547641
   PubMed Web of Science ®Google Scholar
• TashkinDPCelliBSennSUPLIFT Study InvestigatorsA 4-year trial of tiotropium in chronic obstructive pulmonary diseaseN Engl J Med20083591543155418836213
   PubMed Web of Science ®Google Scholar
• CalverleyPMAndersonJACelliBSalmeterol and fluticasone propionate and survival in chronic obstructive pulmonary diseaseN Engl J Med200735677578917314337
   PubMed Web of Science ®Google Scholar
• AnthonisenNRSkeansMAWiseRAManfredaJKannerREConnettJELung Health Study Research GroupThe effects of a smoking cessation intervention on 14.5-year mortality: a randomized clinical trialAnn Intern Med200514223323915710956
   PubMed Web of Science ®Google Scholar
• CazzolaMMateraMGDonnerCFInhaled beta2-adrenoceptor agonists: cardiovascular safety in patients with obstructive lung diseaseDrugs2005651595161016060696
   PubMed Web of Science ®Google Scholar
• LeeTAPickardASAuDHBartleBWeissKBRisk for death associated with medications for recently diagnosed chronic obstructive pulmonary diseaseAnn Intern Med200814938039018794557
   PubMed Web of Science ®Google Scholar
• MacieCWooldrageKManfredaJAnthonisenNCardiovascular morbidity and the use of inhaled bronchodilatorsInt J Chron Obstruct Pulmon Dis2008316316918488440
   PubMedGoogle Scholar
• SinghSLokeYKFurbergCDInhaled anticholinergics and risk of major adverse cardiovascular events in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysisJAMA20083001439145018812535
   PubMed Web of Science ®Google Scholar
• OuchiNParkerJLLugusJJWalshKAdipokines in inflammation and metabolic diseaseNat Rev Immunol201111859721252989
   PubMed Web of Science ®Google Scholar
• OuchiNKiharaSFunahashiTMatsuzawaYWalshKObesity, adiponectin and vascular inflammatory diseaseCurr Opin Lipidol20031456156614624132
   PubMed Web of Science ®Google Scholar
• BreyerMKRuttenEPLocantoreNWWatkinsMLMillerBEWoutersEFCLIPSEInvestigators(Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints). Dysregulated adipokine metabolism in chronic obstructive pulmonary diseaseEur J Clin Invest20124298399122703238
   PubMed Web of Science ®Google Scholar
• LiaoJKLaufsUPleiotropic effects of statinsAnnu Rev Pharmacol Toxicol2005458911815822172
   PubMed Web of Science ®Google Scholar
• LeeJHLeeDSKimEKSimvastatin inhibits cigarette smoking-induced emphysema and pulmonary hypertension in rat lungsAm J Respir Crit Care Med200517298799316002570
   PubMed Web of Science ®Google Scholar
• BandoMMiyazawaTShinoharaHOwadaTTerakadoMSugiyamaYAn epidemiological study of the effects of statin use on airflow limitation in patients with chronic obstructive pulmonary diseaseRespirology20121749349822142478
   PubMed Web of Science ®Google Scholar
• BlamounAIBattyGNDeBariVARashidAOSheikhMKhanMAStatins may reduce episodes of exacerbation and the requirement for intubation in patients with COPD: evidence from a retrospective cohort studyInt J Clin Pract2008621373137818422598
   PubMed Web of Science ®Google Scholar
• SoysethVBrekkePHSmithPOmlandTStatin use is associated with reduced mortality in COPDEur Respir J20072927928317050558
   PubMed Web of Science ®Google Scholar
• LawesCMThornleySYoungRStatin use in COPD patients is associated with a reduction in mortality: a national cohort studyPrim Care Respir J201221354022218819
   PubMedGoogle Scholar